1. Home
  2. GOGO vs QTTB Comparison

GOGO vs QTTB Comparison

Compare GOGO & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gogo Inc.

GOGO

Gogo Inc.

N/A

Current Price

$2.83

Market Cap

461.2M

ML Signal

N/A

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

N/A

Current Price

$15.74

Market Cap

450.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GOGO
QTTB
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
461.2M
450.1M
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
GOGO
QTTB
Price
$2.83
$15.74
Analyst Decision
Hold
Strong Buy
Analyst Count
2
1
Target Price
$15.00
$13.00
AVG Volume (30 Days)
1.6M
944.2K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
136.78
EPS
0.08
N/A
Revenue
$910,491,000.00
$53,737,000.00
Revenue This Year
$3.68
N/A
Revenue Next Year
$3.60
N/A
P/E Ratio
$35.38
N/A
Revenue Growth
104.74
N/A
52 Week Low
$2.77
$1.62
52 Week High
$12.50
$23.57

Technical Indicators

Market Signals
Indicator
GOGO
QTTB
Relative Strength Index (RSI) 32.14 53.91
Support Level N/A $14.26
Resistance Level $4.89 $16.78
Average True Range (ATR) 0.28 1.12
MACD -0.16 -0.15
Stochastic Oscillator 4.30 52.17

Price Performance

Historical Comparison
GOGO
QTTB

About GOGO Gogo Inc.

Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services, and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped. Geographically, it operates in United States; and International as well.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

Share on Social Networks: